TITLE
Cyclooxygenase-2 inhibitor celecoxib effect on colorectal adenocarcinoma

SUMMARY
Analysis of colorectal adenocarcinomas resected from patients treated with celecoxib for 7 days. Celecoxib is a cycooxygenase-2 inibitor that exhibits anti-cancer activity. Results provide insight into the mechanism of action of celecoxib in vivo.

ORGANISM
Homo sapiens

